Infographic: Who’s who in the mRNA Therapeutics Field in Europe?

April 26, 2017

Therapies based on mRNA promise better vaccines and therapeutics by instructing the body to produce its own just by reading the instructions written in the RNA sequence. Thought for a long time to be too unstable to be of therapeutic use, mRNA has been developed by labs and companies around the world to become more stable and efficiently expressed. Now, it can be tweaked at will to either be made invisible for the immune system or trigger a strong immune response to act as a vaccine against cancer or infectious disease.

Spotlight

AQLIVIA GLOBAL RESEARCH

Aqlivia is a global specialty CRO headquartered in Netherlands- India and Middle East, dedicated to serve its clients as a true partner in Pharma drug development, clinical trial. Aqlivia directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America, South Korea. As a premium CRO and being recognized as the quality leader, we focus on the Major therapeutic areas Globally. Aqlivia provides pre-approval and post-market pharmacovigilance (PV) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, medical devices and cosmetics. Our experienced staff deliver Clinical Research and PV services at all levels including specialist, strategic, and safety physician services.

Other Infographics
news image

Designing Genetic Circuit

Infographic | April 13, 2020

Near the turn of the millennium, James Collins and Stanislas Leibler independently undertook rather similar projects: design what would become synthetic biology’s seminal genetic circuits. And they came up with strikingly similar action plans—use E. coli to pair promoters with repressors that control one another’s behavior.

Read More
news image

Merck’s 23 CRISPR Patents Leading the way in genome-editing technology

Infographic | April 7, 2020

CRISPR Integration: CRISPR/Cas9 System for insertion in eukaryotic cells Compositions and use of CRISPR/Cas9 to integrate a new sequence of DNA after cutting genomic DNA. CRISPR-chrom: Improves access to the genome so that CRISPR-driven edits can be done more efficiently.

Read More
news image

Next-Gen Genetics: Cancer Therapies Create Investment Prospects

Infographic | August 12, 2022

The field (gene therapy) is not standing still, it’s evolving rapidly. If we have this discussion again in 18 months’ time, I don't know what we’ll be using then.

Read More
news image

Building the European biotech sector with world-class science and innovation

Infographic | August 5, 2021

Europe continues to be a powerhouse of science and innovation. The region maintains a clear lead over China, the United States, and the rest of the world in terms of the quality and quantity of its science. For example, Europe is home to 43 of the global top 100 life-science universities, while the United States has 34. Europe is a powerhouse in scientific publishing as well, with roughly twice the output of the United States and three times that of China.Europe also leads in terms of quality, as measured by the number of citations for its publications. More than 40,000 biotech patents have been granted in Europe since 2015, although the region’s 3 percent CAGR in patent approvals between 2015 and 2019 lagged behind that of the United States (4 percent) and was a fraction of China’s (14 percent).Despite Europe’s strength in science and innovation, translation remains the biggest challenge. Translation of science into companies is stagnant. The distribution of newly funded biotechs remains unchanged across geographies over the last six years, and Europe accounts for only 25 percent of new biotechs. Future success will depend on improving the translation of research into new companies, raising more capital, and building entrepreneurial talent.

Read More
news image

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body

Infographic | April 16, 2020

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body. This infographic shows the events that occur following SARS-CoV-2 infection

Read More
news image

RNA sequencing libraries

Infographic | April 7, 2020

As part of our In Focus on RNA sequencing for cancer research, we put together an infographic to provide top tips on the preparation of RNA sequencing libraries, the best metrics to use when analyzing your libraries and suggestions for efficient and effective kits for the preparation of each library type.

Read More

Spotlight

AQLIVIA GLOBAL RESEARCH

Aqlivia is a global specialty CRO headquartered in Netherlands- India and Middle East, dedicated to serve its clients as a true partner in Pharma drug development, clinical trial. Aqlivia directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America, South Korea. As a premium CRO and being recognized as the quality leader, we focus on the Major therapeutic areas Globally. Aqlivia provides pre-approval and post-market pharmacovigilance (PV) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, medical devices and cosmetics. Our experienced staff deliver Clinical Research and PV services at all levels including specialist, strategic, and safety physician services.

Events